GlobalData spans many industries with reports, dashboards, and pipeline data. One Zyme does one industry deeply, and reasons across every biopharma signal in real time instead of handing you a static report.
GlobalData is broad by design, covering dozens of sectors. In biopharma, that breadth comes at the cost of the depth and immediacy strategy teams actually need.
One Zyme is built for biopharma alone, so it carries context, down to mechanism, modality, and local-language filing, that a multi-sector platform cannot.
Instead of downloading a report that is dated the day it ships, ask a live question and get a cited synthesis refreshed continuously.
One Zyme reads China’s regulatory, clinical, patent, and corporate sources natively, a persistent blind spot for generalist market-intelligence tools.
Generic reports; you adapt them to your priorities.
Many industries; pharma is one of many.
Reports & dashboards; you interpret and update.
Pipeline, deals, epidemiology as separate datasets.
Generalist, English-centric.
Report-cycle lag.
Broad but generic.
See One Zyme run live on a target of your choice, and compare the answer to what your current stack returns.
